PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma
Yohei Sekino(Hiroshima University), Akio Matsubara(Hiroshima General Hospital)
Cited by 31
Related Papers
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
|Journal of Clinical Medicine|2019|55
Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells
|Oncology Reports|2014|15
CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma
|Anticancer Research|2021|13